Combined, Pfizer Inc and Moderna Inc have forecast a total of over $45 billion in sales this year for their Covid-19 vaccines. Among companies with Covid-19 vaccines, shares of Pfizer fell 1.7% and were among the biggest weights on the benchmark S&P 500 index, while US shares of its German partner BioNTech SE shed 0.6% after falling as much as 15% earlier. Shares of other US companies developing Covid-19 vaccines were shaken. Vaccine maker shares lost ground elsewhere, with Germany's Curevac NV, which has sought approval for its Covid-19 vaccine, tumbling 18%. Shares of China's CanSino Biologics Inc, which makes a single-dose Covid-19 vaccine, were off 15%.

Source: Dhaka Tribune May 06, 2021 18:22 UTC